Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Weak Euro hits Fresenius profit estimates:

This article was originally published in Clinica

Executive Summary

Dialysis company Fresenius Medical Care (FMC) expects to have currency adjusted sales growth of over 10% this financial year, with a 25% increase in net income. The German company originally expected net income growth of up to 30%, but revised its estimates because of the weak euro in the first half, Bad Homburg-based FMC said. It has filed with the US Securities and Exchange Commission and the Frankfurt stock exchange for a global offering. It plans to use the proceeds to fund acquisitions (see Clinica No 914, p 9).

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076581

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel